ARTICLE | Clinical News
Fentora regulatory update
July 25, 2011 7:00 AM UTC
FDA approved a REMS for Fentora fentanyl effervescent buccal tablet from Cephalon to manage breakthrough pain in opioid-tolerant patients with cancer. Under the REMS, pharmacy and healthcare professio...